LIFE
SCIENCE
BUSINESS
Drug Delivery Technology
Cell Therapy Production/
Biopharmaceutical Production
Immunology/Microbiology

Business
Development

Product
Launch

Technology
Assessment

Randall Engler
CEO, Sea.Bio
Randy focuses the efforts of Sea.Bio on global business development of B2B technologies in therapeutic, diagnostic and device markets. With a significant technical background and years of business development, sales and marketing experience, Randy can help you make better decisions by defining, targeting and implementing your business plans for successful commercialization of your technology.